The Texas Pharmacy Association has asked the U.S. Food and Drug Administration to not finalize a proposed rule on importation of prescription drugs.
The proposed rule “introduces unnecessary risks to patient safety and threatens pharmacists’ ability to optimize medication outcomes for their patients, as these products are not distributed with the same safeguards as products distributed in the U.S.,” TPA wrote in a letter submitted March 9. “The proposed program is also unlikely to result in a significant reduction in the cost of prescription drugs to the American consumer.”
TPA also expressed concerns that the proposed program as designed contemplates the inclusion of pharmacy benefit managers (PBMs) in the importation supply chain, given that PBMs are not currently acting in the best interest of patients.
Email to a Friend
The Texas Pharmacy Association has asked the U.S. Food and Drug Administration to not finalize a proposed rule on importation of prescription drugs.
